About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Atherosclerosis Plus
›
top-articles
Atherosclerosis Plus
0.9
(top 50%)
impact factor
137
(top 100%)
papers
142
(top 50%)
citations
5
(top 50%)
h
-index
0.9
(top 50%)
extended IF
158
all documents
172
doc citations
9
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study
Atherosclerosis Plus
2021
17
2
High-density lipoprotein cholesterol: A marker of COVID-19 infection severity?
Atherosclerosis Plus
2021
15
3
Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
Atherosclerosis Plus
2021
9
4
Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study
Atherosclerosis Plus
2022
8
5
High baseline fetuin-A levels are associated with lower atherosclerotic plaque progression as measured by 3D ultrasound
Atherosclerosis Plus
2021
6
6
Colchicine reduces atherosclerotic plaque vulnerability in rabbits
Atherosclerosis Plus
2021
6
7
Clinical characteristics and cardiovascular outcomes among young patients with acute myocardial infarction in Kerala, India: A secondary analysis of ACS QUIK trial
Atherosclerosis Plus
2022
6
8
Association between Helicobacter pylori infection and carotid atherosclerosis in Chinese adults
Atherosclerosis Plus
2021
5
9
Utilization of IVUS improves all-cause mortality in patients undergoing invasive coronary angiography
Atherosclerosis Plus
2021
5
10
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profile
Atherosclerosis Plus
2021
5
11
Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-up
Atherosclerosis Plus
2023
5
12
Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular disease
Atherosclerosis Plus
2022
4
13
Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
Atherosclerosis Plus
2022
4
14
Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with very high lipoprotein (a) levels
Atherosclerosis Plus
2022
4
15
Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease
Atherosclerosis Plus
2023
4
16
Assessment of plasma ceramides as predictor for subclinical atherosclerosis
Atherosclerosis Plus
2021
3
17
Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review
Atherosclerosis Plus
2021
3
18
Tamoxifen-independent Cre-activity in SMMHC-CreER mice
Atherosclerosis Plus
2022
3
19
Atherosclerosis severity in patients with familial hypercholesterolemia: The role of T and B lymphocytes
Atherosclerosis Plus
2022
3
20
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression
Atherosclerosis Plus
2023
3
21
SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease
Atherosclerosis Plus
2023
3
22
Impact of atherosclerotic extent on clinical outcome for diabetic patients with non-obstructive coronary artery disease
Atherosclerosis Plus
2021
2
23
Differential association of flow velocities in the carotid artery with plaques, intima media thickness and cardiac function
Atherosclerosis Plus
2021
2
24
Age dependent association between remnant cholesterol and cardiovascular disease
Atherosclerosis Plus
2021
2
25
Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study
Atherosclerosis Plus
2021
2
26
Urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes
Atherosclerosis Plus
2021
2
27
Hypoglycemia-induced changes in complement pathways in type 2 diabetes
Atherosclerosis Plus
2021
2
28
Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy
Atherosclerosis Plus
2022
2
29
Urine ketone bodies and adverse outcomes in patients with acute ischemic stroke or TIA
Atherosclerosis Plus
2022
2
30
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
Atherosclerosis Plus
2022
2
31
Lipids, lipoproteins and prevalence of familial hypercholesterolemia in the Faroe Islands – Results from a nationwide laboratory database
Atherosclerosis Plus
2022
2
32
Circular RNA expression profile of H2O2 induced ferroptosis model of human coronary artery endothelial cells
Atherosclerosis Plus
2022
2
33
The circulating furin-cleaved/mature PCSK9 ratio has a potential prognostic significance in statin-naïve patients with acute ST elevation myocardial infarction
Atherosclerosis Plus
2022
2
34
Periostin contributes to the adventitial remodeling of atherosclerosis by activating adventitial fibroblasts
Atherosclerosis Plus
2022
2
35
Dyslipidemia and the preventive potential in the Greenlandic population
Atherosclerosis Plus
2023
2
36
HDL and chronic kidney disease
Atherosclerosis Plus
2023
2
37
The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction
Atherosclerosis Plus
2023
2
38
Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
Atherosclerosis Plus
2023
2
39
The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome
Atherosclerosis Plus
2023
2
40
Smad2 inhibition of MET transcription potentiates human vascular smooth muscle cell apoptosis
Atherosclerosis Plus
2021
1
41
Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
Atherosclerosis Plus
2021
1
42
The West Midland Familial Hypercholesterolaemia (FH) screening programme: Evaluating the utility of the 12 SNP polygenic risk score (PRS) across ethnic groupings
Atherosclerosis Plus
2021
1
43
Association of remnant cholesterol with intra- and extra-cranial atherosclerosis in Chinese community population
Atherosclerosis Plus
2021
1
44
Identification of the atherosclerosis phenotype in vivo by vascular duplex ultrasonography in ApoE-deficient dogs
Atherosclerosis Plus
2022
1
45
Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events
Atherosclerosis Plus
2022
1
46
Secular trends in serum lipid profiles in young adults in Norway, 2001-19
Atherosclerosis Plus
2022
1
47
A PCSK9 inhibitor induces a transient decrease in the neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygous familial hypercholesterolemia patients
Atherosclerosis Plus
2022
1
48
Semaglutide treatment attenuates vessel remodelling in ApoE−/− mice following vascular injury and blood flow perturbation
Atherosclerosis Plus
2022
1
49
Novel protein-truncating variant in the APOB gene may protect from coronary artery disease and adverse cardiovascular events
Atherosclerosis Plus
2022
1
50
Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
Atherosclerosis Plus
2022
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.